Chiung-Fang Shiu

Title: Chiung-Fang Shiu: Innovator in Cancer Therapy

Introduction

Chiung-Fang Shiu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer therapy through his innovative methods. His work focuses on improving treatment outcomes for cancer patients by utilizing plasma arginine levels.

Latest Patents

Chiung-Fang Shiu holds a patent for "Methods for predicting response to arginine deprivation therapy based on plasma arginine levels in cancer patients." This patent describes a method for predicting whether a cancer patient will benefit from arginine deprivation therapy. The process involves determining the plasma level of arginine in the patient and subsequently administering arginine deprivation therapy, either alone or in combination with an anti-cancer agent, based on the determined plasma level.

Career Highlights

Chiung-Fang Shiu is associated with Polaris Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to enhance cancer treatment methodologies.

Collaborations

He collaborates with esteemed colleagues, including Hung-Wen Chen and Shaw Tsen Chen, to further his research initiatives and explore new therapeutic avenues.

Conclusion

Chiung-Fang Shiu's innovative approach to cancer therapy exemplifies the potential of targeted treatment strategies. His contributions are vital in the ongoing battle against cancer, showcasing the importance of research and innovation in medicine.